References
- Money KE, Lackner JR, Cheung RSK. The autonomic nervous system and motion sickness. In: Yates BJ, Miller AD, eds. Vestibular Autonomic Regulation. Boca Raton, FL: CRC Press; 1996:147–173.
- Matsunaga T, Kubo T. Neuropharmacology of motion sickness and emesis. A review. Acta Otolaryngol. 1993;501(Suppl):10–15.
- Drug Facts and Comparisons. Pocket Version, 18th ed. St. Louis, MO: 2004;866.
- Illum L. Nasal drug delivery – possibilities, problems and solutions. J Controlled Rel. 2003;87:187–198.
- Jiang X, Cao S, Chen E, Zhang Q. Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy. Acta Pharmacol Sinica. 2007;28(4):584–590.
- Balasubramaniam J, Kant S, Pandit JK. In vitro and in vivo evaluation of the Gelrite® gellan gum-based ocular delivery system for indomethacin. Acta Pharm. 2003;53:251–261.
- Watts PJ, Illum L. Pectin compositions for improved delivery of drugs to mucosal membranes. 2002; US Patent: 6,432,440.
- Yong CS, Choi JS, Rhee JD, et al. Effect of sodium chloride on the gelation, gel strength, and bioadhesive force of poloxamer gels. Int J Pharm. 2001;275:195–205.
- Murthy RSR, Majithiya RJ, Ghosh PK, et al. Thermoreversible-mucoadhesive gel for nasal delivery of Sumatriptan. AAPS. Pharm Sci Tech. 2006;7(3):E1–7.
- Zaki NM, Awada GA, Mortadaa ND, et al. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm. Sci. 2007;32:296–307.
- Behl CR, Harper NJ, Pei JY, et al. A general method of accessing skin permeation enhancement mechanisms and optimization. In: Hsies DS, ed. Drug Permeation Enhancement: Theory and Applications. 1st ed. New York, NY: Marcel Dekker Inc.; 1994:115.
- Jiang X, Cao S, Chen E, Zhang Q. A novel nasal delivery system of a chinese traditional medicine, radix bupleuri, based on the concept of ion- activated in situ gel. Arch Pharm Res. 2007;30(8):1014–1019.